Gender-Based Differences in Outcomes After Percutaneous Coronary Intervention of Chronic Total Occlusions (Insights

Htoo Kyaw1, Gennaro Giustino1, Suwen Kumar1

  • 1The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

PubMed

Insights

Women undergoing percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) face higher risks of complications and worse outcomes at one year compared to men. This study highlights potential gender disparities in CTO-PCI, necessitating further investigation into tailored care strategies.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Outcomes Research

Background:

  • Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) carries significant risks.
  • Existing literature lacks clarity on gender-based outcome differences following CTO-PCI.

Purpose of the Study:

  • To investigate gender-based differences in outcomes after elective CTO-PCI.
  • To identify specific complications and adverse events associated with female gender in CTO interventions.

Main Methods:

  • Retrospective analysis of 1,897 patients undergoing elective CTO-PCI between 2012 and 2017.
  • Primary endpoint: major adverse cardiac events (death, myocardial infarction, target vessel revascularization) at 1-year follow-up.
  • Multivariable analysis to adjust for patient co-morbidities and demographic factors.

Main Results:

  • Women were older and had more comorbidities (diabetes, chronic kidney disease).
  • No significant difference in successful CTO-PCI rates between genders.
  • Women experienced higher rates of procedure-related bleeding and acute vessel closure.
  • Female gender was independently associated with increased 1-year major adverse cardiac events and target vessel revascularization.

Conclusions:

  • Women undergoing CTO-PCI face higher periprocedural complication rates and worse 1-year clinical outcomes than men.
  • Findings suggest potential gender disparities in CTO-PCI outcomes.
  • Further research is warranted to address and mitigate these gender-specific outcome differences.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30